Product Name | KNK 437 |
Description |
HSP70 Inhibitor |
Purity | >98% (HPLC); NMR (conforms) |
CAS No. | 218924-25-5 |
Molecular Formula | C13H11NO4 |
Molecular Weight | 245.2 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | May be dissolved in DMSO (30 mg/ml) |
Source | Synthetic |
Appearance | Off-white powder |
SMILES | C1CN(C(=O)C1=CC2=CC3=C(C=C2)OCO3)C=O |
InChI | InChI=1S/C13H11NO4/c15-7-14-4-3-10(13(14)16)5-9-1-2-11-12(6-9)18-8-17-11/h1-2,5-7H,3-4,8H2/b10-5+ |
InChIKey | LZGGUFLRKIMBDQ-BJMVGYQFSA-N |
Safety Phrases |
Classification: Caution: Substance not yet fully tested. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection |
Cite This Product | KNK 437 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-599) |
Alternative Names | 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde |
Research Areas | Cancer, Heat Shock |
PubChem ID | 46195007 |
Scientific Background | KNK 437 is an inhibitor of the acquisition of thermotolerance caused by the induction of HSPs, including HSP105, HSP70, and HSP40 in human colon carcinoma cells (1). It has also been tested in anti-tumor therapy of colorectal cancer (2). |
References | 1. Yokota S., Kitahara M., and Nagata K. (2000) Cancer Res. 60 (11): 2942-2948. 2. Yang S., et al. (2020) Oncogene. 39: 249-261. |
Reviews
There are no reviews yet.